Jacqueline Dela Merced, MD
Obstetrics & Gynecology · Greenbrae, CANPI 1245536234
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $890 of the $1,099 with a category attached, or 81.0%. 14 manufacturers reported payments, led by Therapeuticsmd, Inc. at 24.5% of the total. Reporting peaked in 2019 at $445 and has fallen 96.0% since, to $18 in 2024.
Across 62 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Therapeuticsmd, Inc.$270
- AbbVie$217
- Bayer$131
- AMAG Pharmaceuticals, Inc.$110
- Myovant Sciences Inc.$83
- Merck$67
- plus $223 from 8 others
What the payments were for
- Food & beverage$89081%
- Education$20919%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Therapeuticsmd, Inc. | 16 | $270 |
| AbbVie(2 entities) | 11 | $217 |
| Bayer | 6 | $131 |
| AMAG Pharmaceuticals, Inc. | 9 | $110 |
| Myovant Sciences Inc. | 4 | $83 |
| Merck | 4 | $67 |
| Hologic Sales And Service, LLC | 2 | $49 |
| Coopersurgical, Inc. | 3 | $48 |
| Lupin Inc. | 2 | $30 |
| Organon | 1 | $24 |
| Roche Diagnostics Corporation | 1 | $21 |
| Meditrina | 1 | $18 |
| Avion Pharmaceuticals | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
How this compares
$1,099 in reported general payments places this provider in the 65th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $1,119 |
| Estradiol (Twice Weekly)Estradiol | 17 | $849 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Greenbrae
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.